Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation
European Heart Journal Open · 06.07.2024 · 4 (4)
DOI: 10.1093/ehjopen/oeae046 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 12.06.2024. Verfasst von Tanja Knopp und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology-Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Aims
The cytokine interleukin-6 (IL-6) plays a central role in the inflammation cascade as well as cardiovascular disease progression. Since myeloid cells are a primary source of IL-6 formation, we aimed to generate a mouse model to study the role of myeloid cell-derived IL-6 in vascular disease. Methods and results Interleukin-6-overexpressing (IL-6OE) mice were generated and crossed with LysM-Cre mice, to generate mice (LysM-IL-6OE mice) overexpressing the cytokine in myeloid cells. Eight- to 12-week-old LysM-IL-6OE mice spontaneously developed inflammatory colitis and significantly impaired endothelium-dependent aortic relaxation, increased aortic reactive oxygen species (ROS) formation, and vascular dysfunction in resistance vessels. The latter phenotype was associated with decreased survival. Vascular dysfunction was accompanied by a significant accumulation of neutrophils, monocytes, and macrophages in the aorta, increased myeloid cell reactivity (elevated ROS production), and vascular fibrosis associated with phenotypic changes in vascular smooth muscle cells. In addition to elevated Mcp1 and Cxcl1 mRNA levels, aortae from LysM-IL-6OE mice expressed higher levels of inducible NO synthase and endothelin-1, thus partially accounting for vascular dysfunction, whereas systemic blood pressure alterations were not observed. Bone marrow (BM) transplantation experiments revealed that vascular dysfunction and ROS formation were driven by BM cell-derived IL-6 in a dose-dependent manner.
Conclusion
Mice with conditional overexpression of IL-6 in myeloid cells show systemic and vascular inflammation as well as endothelial dysfunction. A decrease in circulating IL-6 levels by replacing IL-6-producing myeloid cells in the BM improved vascular dysfunction in this model, underpinning the relevant role of IL-6 in vascular disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology-Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
- Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
- Institute of Molecular Medicine, University Medical Center Mainz, Mainz, Germany.
- German Center for Cardiovascular Research (DZHK), Partner site Rhine-Main, Germany.
- Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
- Institute of Anatomy, University Medical Center Leipzig, Leipzig, Germany.
ORCID-Profile: Tanja Knopp, Johannes Wild, Magdalena L Bochenek, Panagiotis Efentakis, Tabea Bieler, Venkata Garlapati, Cindy Richter, Michael Molitor, Jérémy Lagrange, Voahanginirina Randriamboavonjy, Thomas Wunderlich, Nadine Hövelmeyer, Ilgiz A Mufazalov, Markus Bosmann, Ingrid Fleming, Matthias Oelze, Andreas Daiber, Thomas Münzel, Katrin Schäfer, Philip Wenzel, Ari Waisman, Susanne Karbach
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Knopp, T., Jung, R., Wild, J., Bochenek, M. L., Efentakis, P., Lehmann, A., Bieler, T., Garlapati, V., Richter, C., Molitor, M., Perius, K., Finger, S., Lagrange, J., Ghasemi, I., Zifkos, K., Kommoss, K. S., Masri, J., Reißig, S., Randriamboavonjy, V., …, & Karbach, S. (2024). Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation. European Heart Journal Open, 4(4). https://doi.org/10.1093/ehjopen/oeae046
Vancouver
Knopp T, Jung R, Wild J, Bochenek ML, Efentakis P, Lehmann A, et al. Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation. European Heart Journal Open. 2024;4(4). doi:10.1093/ehjopen/oeae046
BibTeX
@article{Knopp2024,
author = {Knopp, Tanja and Jung, Rebecca and Wild, Johannes and Bochenek, Magdalena L and Efentakis, Panagiotis and Lehmann, Annika and Bieler, Tabea and Garlapati, Venkata and Richter, Cindy and Molitor, Michael and Perius, Katharina and Finger, Stefanie and Lagrange, Jérémy and Ghasemi, Iman and Zifkos, Konstantinos and Kommoss, Katharina S and Masri, Joumana and Reißig, Sonja and Randriamboavonjy, Voahanginirina and Wunderlich, Thomas and Hövelmeyer, Nadine and Weber, Alexander N R and Mufazalov, Ilgiz A and Bosmann, Markus and Bechmann, Ingo and Fleming, Ingrid and Oelze, Matthias and Daiber, Andreas and Münzel, Thomas and Schäfer, Katrin and Wenzel, Philip and Waisman, Ari and Karbach, Susanne},
title = {Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation},
journal = {European Heart Journal Open},
year = {2024},
volume = {4},
number = {4},
doi = {10.1093/ehjopen/oeae046}
}
EUVIMED